Search

Your search keyword '"Eleonora Rigoni"' showing total 17 results

Search Constraints

Start Over You searched for: Author "Eleonora Rigoni" Remove constraint Author: "Eleonora Rigoni"
17 results on '"Eleonora Rigoni"'

Search Results

1. Beyond Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies: Alternative Causes of Optic Neuritis

2. The Potential Role of SARS-CoV-2 Infection and Vaccines in Multiple Sclerosis Onset and Reactivation: A Case Series and Literature Review

3. The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study

4. The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis

5. The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study

6. Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study

7. Primary central nervous system lymphoma mimicking autoimmune encephalitis: the role of autoantibody testing

8. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

9. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context

10. Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in Italy

11. Development of Autoimmune Thyroid Disease in Multiple Sclerosis Patients Post-Alemtuzumab Improves Treatment Response

12. Cell-based assays for the detection of MOG antibodies: a comparative study

13. Comorbidity in people with multiple sclerosis. A cross-sectional study in two Italian areas

14. Myelin oligodendrocyte glycoprotein (MOG) antibody titres and retinal degeneration in MOG-associated disease: A single centre Italian study

15. Administrative data to estimate the burden of major comorbidities in multiple sclerosis. A cross-sectional study in two Italian areas

16. Development of auto-immune thyroid dysfunction in multiple sclerosis patients receiving Alemtuzumab is associated with improved response to treatment

17. Signs and symptoms of COVID-19 in patients with multiple sclerosis

Catalog

Books, media, physical & digital resources